Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|107|9|1243-1249

ISSN： 1347-9032

Source： Cancer Science, Vol.107, Iss.9, 2016-09, pp. : 1243-1249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2X7 receptor predicts postoperative cancer‐specific survival of patients with clear‐cell renal cell carcinoma

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1224-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2X7 receptor predicts postoperative cancer‐specific survival of patients with clear‐cell renal cell carcinoma

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1224-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

High expression of interleukin‐11 is an independent indicator of poor prognosis in clear‐cell renal cell carcinoma

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 592-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 687-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular‐targeted therapy

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 618-626

John Wiley & Sons Inc

Access to resources Recommend Favorite